Charles River Laboratories | CRL - Pre Tax Profit

Stock Price
178.49
Daily Change
3.03 1.73%
Monthly
-17.70%
Yearly
7.97%
Q1 Forecast
163.68

Charles River Laboratories reported $170.03M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Agilent USD 442M 1000K Sep/2025
Align Technology USD 176.6M 81.86M Dec/2025
Bio-Rad Laboratories USD 82.9M 331.1M Sep/2025
Bruker USD -72.6M 73.1M Sep/2025
Cardinal Health USD 598M 214M Sep/2025
Charles River Laboratories USD 170.03M 98.62M Sep/2025
Cigna USD 2.3B 274M Sep/2025
CVS Health USD 1.35B 4.84B Dec/2025
Danaher USD 1.08B 421M Sep/2025
Dentsply International USD -230M 77M Sep/2025
Elevance Health USD 215M 1.19B Dec/2025
Galapagos EUR -221.49M 117.07M Sep/2025
Hologic USD 229.7M 2.3M Dec/2025
Humana USD 527M 214M Sep/2025
Illumina USD 220M 86M Sep/2025
Incyte USD 389.94M 92.37M Dec/2025
Intrexon USD -60.48M 27.09M Jun/2024
IQVIA Holdings USD 6.16B 5.84B Sep/2025
Laboratory Of America USD 337M 32.3M Sep/2025
Lonza CHF 624M 197M Dec/2024
McKesson USD 1.4B 344M Sep/2025
Merck EUR 1.29B 458.1M Sep/2025
Mettler Toledo International USD 269.24M 20.58M Sep/2025
Novartis USD 4.2B 335M Sep/2025
Pfizer USD 3.33B 290M Sep/2025
Quest Diagnostics USD 336M 57M Sep/2025
Revvity USD 55.68M 115.97M Sep/2025
Thermo Fisher Scientific USD 2.12B 295M Dec/2025
United Therapeutics USD 444M 6M Dec/2025
UnitedHealth USD 3.23B 1.16B Sep/2025
Veradigm USD 35.3M 94.8M Sep/2022
Waters USD 170.12M 7.57M Sep/2025
West Pharmaceutical Services USD 170.1M 8.1M Sep/2025